Biomarker-driven protocols

Understanding the markers that shape your plan.

Long-form explanations of the biomarkers, physiological mechanisms, and clinical trade-offs behind the protocols Xcergy builds.

Evidence-based research on South Asian metabolic health, ApoB vs LDL discordance, HOMA-IR calculations, wearable HRV mathematics, and automated safety gates.

Biomarker & Wearable Command Center

Your entire biological loop in a single command center.

Most health apps trap you into fragmented silos: one for gym workouts, one for calorie counting, one for wearable sleep scores, and PDFs sitting lost in email threads.

Xcergy unifies all streams. Your morning readiness score dynamically adjusts today's working volume, your lab biomarkers govern nutritional macro balance, and your coach has immediate context without scheduling a call.

Answers the only morning question that matters: what should I train, what should I eat, and what is my body ready for today?

Apple Health & Health ConnectOptical Food VisionReal-time Domain Radar
Xcergy member exploring metabolic intelligence on iPhone
90+ Biomarkers Synced
Dynamic Morning Readiness

Auto-calibrated workout loads

Featured clinical evidence

The papers behind the protocol.

Peer-reviewed literature basis
ApoB trend · 90 days114 → 86 mg/dL
BaselineCurrent
LipidologyResearch note 01
7 min read

Why ApoB Outperforms LDL-C in South Asian Cardiovascular Risk

Traditional cholesterol panels measure total cholesterol mass within LDL particles (LDL-C). In South Asian phenotypes with high triglycerides and insulin resistance, LDL particles become small and dense. ApoB measures the exact count of atherogenic particles, identifying hidden vascular risk that normal LDL-C masks.

Key takeaways
  • Every atherogenic particle (LDL, VLDL, IDL, Lp(a)) carries exactly one molecule of ApoB-100.
  • Discordance (normal LDL-C but elevated ApoB) is significantly higher in South Asian populations.
  • ApoB particles penetrate the vascular endothelium, driving plaque initiation and progression.

Source · European Heart Journal / ESC & ACC/AHA Scientific Consensus on Atherogenic Lipoproteins

Explore Biomarker Panels
Insulin response · HOMA-IR2.4
Glucose
102
Insulin
9.6
Early resistance signalContext required
Metabolic HealthResearch note 02
5 min read

Understanding HOMA-IR: Calculating Early Insulin Resistance in South Asians

How fasting plasma glucose and fasting insulin interact via the HOMA-IR mathematical model to predict metabolic dysfunction years before clinical HbA1c elevation or diabetes diagnosis.

Key takeaways
  • The South Asian threshold for insulin resistance is lower (~1.8 vs standard Western 2.5).
  • Normal blood glucose accompanied by elevated fasting insulin signals compensated beta-cell stress.
  • Strength training and post-meal muscle glycogen depletion rapidly restore insulin sensitivity.

Source · Matthews et al., Diabetologia & ICMR Guidelines on Early Dysglycemia Screening

View Metabolic Markers

Evidence Desk & Mechanism Explanations

11 articles available
Lipidology
7 min read

Why ApoB Outperforms LDL-C in South Asian Cardiovascular Risk

Traditional cholesterol panels measure total cholesterol mass within LDL particles (LDL-C). In South Asian phenotypes with high triglycerides and insulin resistance, LDL particles become small and dense. ApoB measures the exact count of atherogenic particles, identifying hidden vascular risk that normal LDL-C masks.

Core mechanism:

Every atherogenic particle (LDL, VLDL, IDL, Lp(a)) carries exactly one molecule of ApoB-100.

Metabolic Health
5 min read

Understanding HOMA-IR: Calculating Early Insulin Resistance in South Asians

How fasting plasma glucose and fasting insulin interact via the HOMA-IR mathematical model to predict metabolic dysfunction years before clinical HbA1c elevation or diabetes diagnosis.

Core mechanism:

The South Asian threshold for insulin resistance is lower (~1.8 vs standard Western 2.5).

Metabolic Health
6 min read

HbA1c: What a Rising Trend Means Before Clinical Diabetes

Why an HbA1c shift from 5.4% to 6.2% within eight months carries critical clinical urgency even while technically staying within standard reference ranges, and how slope detection guides preventive nutrition.

Core mechanism:

Rate of change (slope) predicts microvascular risk earlier than static cutoff values.

Clinical Protocols
5 min read

Why High Systemic Inflammation (hs-CRP) Must Gate HIIT Training

How elevated hs-CRP (> 3.0 mg/L) signals systemic vascular and cellular inflammation where high-intensity glycolytic workouts exacerbate endothelial strain, and why Xcergy automatically routes members to Zone 2 recovery.

Core mechanism:

High systemic inflammation impairs cellular repair, muscle protein synthesis, and sleep architecture.

Clinical Protocols
6 min read

Zone 2 Aerobic Base: Measured LT1 vs Population Formulas

Why calculating Zone 2 heart rate via '220 minus age' carries an error margin of ±11 bpm, shifting training into the wrong metabolic zone, and how measured LT1 talk tests set the true aerobic ceiling.

Core mechanism:

Zone 2 maximizes fat oxidation rates and mitochondrial lactate clearance capacity.

Wearable Science
6 min read

CGM for Non-Diabetics: What Continuous Glucose Variability Teaches

How continuous glucose telemetry uncovers post-prandial glycemic excursions, nocturnal dawn spikes, and food-specific spikes that single annual blood draws miss entirely.

Core mechanism:

Glycemic variability (standard deviation & CV%) correlates directly with vascular oxidative stress.

Nutrition
5 min read

Vitamin D & B12 Micronutrient Deficiencies in India: Protocol Repletion

Over 70% of urban Indians exhibit sub-optimal 25(OH)D and B12 levels. How micronutrient repletion improves mitochondrial oxidative capacity, homocysteine clearance, and neuromuscular recovery.

Core mechanism:

Vitamin D regulates over 1,000 genomic pathways, including skeletal muscle protein synthesis.

Nutrition
6 min read

Fatty Liver Risk (MASLD) & Targeted Lifestyle Protocols

Metabolic dysfunction-associated steatotic liver disease (MASLD) frequently occurs at normal BMI in South Asians. How ALT/AST ratios, de novo lipogenesis, and resistance training reverse hepatic fat.

Core mechanism:

Hepatic steatosis manifests at lower BMI thresholds in South Asians due to constrained subcutaneous storage.

Wearable Science
7 min read

HRV Science: Mathematical Difference Between SDNN and RMSSD

Why comparing Apple Health 24-hour SDNN against Oura / Health Connect nighttime RMSSD distorts recovery analysis, and how Xcergy keeps biometric telemetry baselines mathematically segregated.

Core mechanism:

RMSSD reflects short-term parasympathetic vagal modulation and nocturnal recovery depth.

Workforce Health
5 min read

Corporate Preventive Health Without Employee Privacy Risk

How cryptographic isolation and k-anonymity cohort aggregation give leadership workforce metabolic insights while strictly preventing HR or insurance from ever viewing individual health records.

Core mechanism:

Individual blood test results and glucose traces are cryptographically partitioned from employer access.

Proactive Health
6 min read

Medicine 3.0 in India: What Proactive Health Actually Means

Most healthcare is reactive: you go when something is already wrong, and it treats the symptom. ‘Medicine 3.0’, a term popularised by physician and author Peter Attia, describes a proactive, personalised alternative: reading your own trend data now and acting on it early, before a single test result forces the issue.

Core mechanism:

Medicine 2.0 waits for a diagnosis; Medicine 3.0 acts on the trend while you can still shape it.

Clinical Mathematics & Gating Models

Interactive Biomarker Mechanism Explorer

How Xcergy computes metabolic risk ratios, applies South Asian phenotypic thresholds, and triggers automated safety gates in the protocol engine.

Signal → threshold
A trend earns a review when it crosses context.
Biomarker Formula & Model
ApoB-100 Particle Count (mg/dL) vs LDL-C Mass (mg/dL)
South Asian Clinical Threshold
ApoB > 80 mg/dL (Optimal < 65 mg/dL in high risk)
Primary Literature Reference

ESC/EAS Guidelines for the Management of Dyslipidaemias

Pathophysiological Mechanism

Every atherogenic lipoprotein (LDL, VLDL, IDL, Lp(a)) carries exactly one ApoB molecule. When triglycerides are high, LDL particles become smaller and denser. LDL-C mass may appear normal (e.g. 100 mg/dL) while ApoB particle count is dangerously elevated (> 105 mg/dL), trapping cholesterol in arterial walls.

Automated Protocol Action

Prescribe Zone 2 aerobic volume to stimulate lipoprotein lipase, reduce saturated fat intake, and introduce targeted viscous soluble fiber to upregulate hepatic LDL receptor clearance.

Zero Extrapolated Data

When a required biological input is missing, the algorithm outputs “cannot compute” and names the exact missing marker rather than inventing an estimate.

South Asian Reference Ranges

Calibrated to ICMR guidelines, accounting for earlier onset of atherogenic dyslipidemia, lower insulin resistance cutoffs, and MASLD susceptibility.

Physician-Gated Authority

Safety gates identify clinical contraindications in real time. If a physician modifies or locks a threshold, every dashboard and coach check-in follows that directive.